Literature DB >> 24500043

[Topical treatment of infections, tumors and hyperkeratotic disorders].

A Messerschmidt1, K Schultheis, F Ochsendorf.   

Abstract

In this review substances for the topical treatment of skin infections, skin tumors and hyperkeratotic disorders are presented. Substances with specific actions as topical antimycotic, antibiotic, antiseptic, antiviral and antiparasitic agents as well as diclofenac in hyaluronic acid, 5-fluoruracil, imiquimod, ingenol mebutate, bexarotene, mechlorethamine, BCNU, alitretinoin, silicone gel, salicylic acid and urea are discussed with respect to their mode of action, indication and side effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24500043     DOI: 10.1007/s00105-013-2741-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  13 in total

1.  Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies.

Authors:  D Pirard; P Vereecken; C Mélot; M Heenen
Journal:  Arch Dermatol Res       Date:  2005-11-11       Impact factor: 3.017

Review 2.  Effectiveness of 5-fluorouracil treatment for actinic keratosis--a systematic review of randomized controlled trials.

Authors:  Deborah A Askew; Sharon M Mickan; H Peter Soyer; David Wilkinson
Journal:  Int J Dermatol       Date:  2009-05       Impact factor: 2.736

Review 3.  Salicylic acid revisited.

Authors:  A N Lin; T Nakatsui
Journal:  Int J Dermatol       Date:  1998-05       Impact factor: 2.736

4.  Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles.

Authors:  C William Hanke; Kenneth R Beer; Eggert Stockfleth; Jason Wu; Theodore Rosen; Sharon Levy
Journal:  J Am Acad Dermatol       Date:  2010-02-04       Impact factor: 11.527

Review 5.  [Keloid and hypertrophic scar treatment modalities. An update].

Authors:  L K Branski; H O Rennekampff; P M Vogt
Journal:  Chirurg       Date:  2012-09       Impact factor: 0.955

6.  Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.

Authors:  M Duvic; A E Friedman-Kien; D J Looney; S A Miles; P L Myskowski; D T Scadden; J Von Roenn; J E Galpin; J Groopman; G Loewen; V Stevens; J A Truglia; R C Yocum
Journal:  Arch Dermatol       Date:  2000-12

7.  Clinical findings using ingenol mebutate gel to treat actinic keratoses.

Authors:  George Martin; Neil Swanson
Journal:  J Am Acad Dermatol       Date:  2013-01       Impact factor: 11.527

Review 8.  [Ectoparasites. Part 2: Bed bugs, Demodex, sand fleas and cutaneous larva migrans].

Authors:  P Nenoff; W Handrick; C Krüger; J Herrmann; B Schmoranzer; U Paasch
Journal:  Hautarzt       Date:  2009-09       Impact factor: 0.751

Review 9.  [Significance of urea in external therapy].

Authors:  W Wohlrab
Journal:  Hautarzt       Date:  1989       Impact factor: 0.751

Review 10.  Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management.

Authors:  Mahnaz Fatahzadeh; Robert A Schwartz
Journal:  J Am Acad Dermatol       Date:  2007-11       Impact factor: 11.527

View more
  1 in total

1.  A dermocosmetic containing bakuchiol, Ginkgo biloba extract and mannitol improves the efficacy of adapalene in patients with acne vulgaris: result from a controlled randomized trial.

Authors:  Katarína Poláková; Aurélie Fauger; Michèle Sayag; Eric Jourdan
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-04-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.